Endo Pharma to withdraw application for new opioid painkiller formulation #the #pharmaceutical #industry

Posted On Aug 13 2017 by

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …


UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller

Posted On Jul 26 2017 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …


Endo Pharma to withdraw application for new opioid painkiller formulation #top #biopharma #companies

Posted On Jul 8 2017 by

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …


Endo Pharma to withdraw application for new opioid painkiller formulation #generic #pharmaceutical #companies

Posted On May 28 2017 by

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …


UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller

Posted On May 18 2017 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …


Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al

Posted On May 2 2017 by

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …


UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller

Posted On Apr 13 2017 by

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …


Endo Pharma to withdraw application for new opioid painkiller formulation #catalent #pharma #solutions

Posted On Apr 8 2017 by

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …


Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al

Posted On Mar 25 2017 by

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …


Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al

Posted On Feb 6 2017 by

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …